Gilead And Roche Resolve Tamiflu Licensing Dispute
Increased antiviral demand in the face of seasonal flu and the threat of pandemic avian flu leads the firms to settle arbitration over a manufacturing and commercialization agreement.
Increased antiviral demand in the face of seasonal flu and the threat of pandemic avian flu leads the firms to settle arbitration over a manufacturing and commercialization agreement.